A New Leu714Arg Variant in the Converter Domain of MYH7 is Associated with a Severe Form of Familial Hypertrophic Cardiomyopathy
Frontiers in Bioscience-Scholar · 2024
DOI: 10.31083/j.fbs1601001 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Bioscience-Scholar, 2024. Verfasst von Maria V Golubenko und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Medical Genetics, Tomsk National Research Medical Center, Russian Academy of Sciences, 634050 Tomsk, Russia. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Cardiomyopathy, Hypertrophic, Familial. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Max-Planck Society (Germany).
Abstract (Originalsprache)
Background
Hypertrophic cardiomyopathy is the most frequent autosomal dominant disease, yet due to genetic heterogeneity, incomplete penetrance, and phenotype variability, the prognosis of the disease course in pathogenic variant carriers remains an issue. Identifying common patterns among the effects of different genetic variants is important.
Methods
We investigated the cause of familial hypertrophic cardiomyopathy (HCM) in a family with two patients suffering from a particularly severe disease. Searching for the genetic variants in HCM genes was performed using different sequencing methods.
Results
A new missense variant, p.Leu714Arg, was identified in exon 19 of the beta-myosin heavy chain gene (MYH7). The mutation was found in a region that encodes the ‘converter domain’ in the globular myosin head. This domain is essential for the conformational change of myosin during ATP cleavage and contraction cycle. Most reports on different mutations in this region describe severe phenotypic consequences. The two patients with the p.Leu714Arg mutation had heart failure early in life and died from HCM complications.
Conclusions
This case presents a new likely pathogenic variant in MYH7 and supports the hypothesis that myosin converter mutations constitute a subclass of HCM mutations with a poor prognosis for the patient.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Institute of Medical Genetics, Tomsk National Research Medical Center, Russian Academy of Sciences, 634050 Tomsk, Russia.
- Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634050 Tomsk, Russia.
- Department of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, 199034 Saint-Petersburg, Russia.
Förderung
- Max-Planck Society (Germany)
Zitieren
APA
Golubenko, M. V., Pavlyukova, E. N., Salakhov, R. R., Makeeva, O. A., Puzyrev, K. V., Glotov, O. S., Puzyrev, V. P., & Nazarenko, M. S. (2024). A New Leu714Arg Variant in the Converter Domain of MYH7 is Associated with a Severe Form of Familial Hypertrophic Cardiomyopathy. Frontiers in Bioscience-Scholar. https://doi.org/10.31083/j.fbs1601001
Vancouver
Golubenko MV, Pavlyukova EN, Salakhov RR, Makeeva OA, Puzyrev KV, Glotov OS, et al. A New Leu714Arg Variant in the Converter Domain of MYH7 is Associated with a Severe Form of Familial Hypertrophic Cardiomyopathy. Frontiers in Bioscience-Scholar. 2024. doi:10.31083/j.fbs1601001
BibTeX
@article{Golubenko2024,
author = {Golubenko, Maria V and Pavlyukova, Elena N and Salakhov, Ramil R and Makeeva, Oksana A and Puzyrev, Konstantin V and Glotov, Oleg S and Puzyrev, Valery P and Nazarenko, Maria S},
title = {A New Leu714Arg Variant in the Converter Domain of MYH7 is Associated with a Severe Form of Familial Hypertrophic Cardiomyopathy},
journal = {Frontiers in Bioscience-Scholar},
year = {2024},
doi = {10.31083/j.fbs1601001}
}
EUVIMED